HomeMIST • NASDAQ
Milestone Pharmaceuticals Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.53M | 29.69% |
Net income | -12.97M | -38.48% |
Net profit margin | — | — |
Earnings per share | -0.20 | -42.86% |
EBITDA | -12.50M | -29.75% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 43.42M | -47.85% |
Total assets | 47.42M | -46.86% |
Total liabilities | 65.16M | 13.81% |
Total equity | -17.75M | — |
Shares outstanding | 66.40M | — |
Price to book | -7.44 | — |
Return on assets | -57.32% | — |
Return on capital | -71.11% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -12.97M | -38.48% |
Cash from operations | -12.57M | -107.60% |
Cash from investing | 9.94M | 4.87% |
Cash from financing | 36.00K | 112.08% |
Net change in cash | -2.59M | -182.59% |
Free cash flow | -8.88M | -107.18% |
Previous close
$2.01
Day range
$1.95 - $2.04
Year range
$0.63 - $2.75
Market cap
168.29M USD
Avg Volume
1.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2003
Website
Employees
33
